📌📌ANMOL Scheme (Delhi - 2026)

⭕️Full form:

A-Advanced
N-Newborn
M-Monitoring for
O-Optimal
L- Lifecare

⭕️Purpose : Newborn screening
⭕️Detects: 56 genetic & metabolic disorders
⭕️Method : Heel prick blood test
⭕️Benefit : Early treatment → prevents disability

𝗣𝗢𝗟𝗬𝗘𝗡𝗗𝗢𝗖𝗥𝗜𝗡𝗘 𝗠𝗘𝗧𝗔𝗕𝗢𝗟𝗜𝗖 𝗢𝗩𝗔𝗥𝗜𝗔𝗡 𝗦𝗬𝗡𝗗𝗥𝗢𝗠𝗘 (𝗣𝗠𝗢𝗦)
(Previously known as PCOS — Updated Nomenclature 2026)

𝗪𝗛𝗔𝗧 𝗜𝗦 𝗣𝗠𝗢𝗦?

PMOS is the new name for the condition formerly called Polycystic Ovary Syndrome (PCOS). PMOS is primarily a: 𝗛𝗼𝗿𝗺𝗼𝗻𝗮𝗹 + 𝗠𝗲𝘁𝗮𝗯𝗼𝗹𝗶𝗰 disorder,not merely an ovarian cyst disease.

The updated name reflects that the disorder is:

𝗣𝗼𝗹𝘆𝗲𝗻𝗱𝗼𝗰𝗿𝗶𝗻𝗲 → affects multiple hormonal systems
𝗠𝗲𝘁𝗮𝗯𝗼𝗹𝗶𝗰 → strongly linked with insulin resistance & metabolic dysfunction
𝗢𝘃𝗮𝗿𝗶𝗮𝗻 → affects ovulation and ovarian function

𝗖𝗢𝗠𝗠𝗢𝗡 𝗙𝗘𝗔𝗧𝗨𝗥𝗘𝗦

Irregular menstrual cycles
Anovulation / infertility
Hyperandrogenism → acne, hirsutism, alopecia
Insulin resistance
Weight gain / obesity
Polycystic ovarian morphology on ultrasound

𝗠𝗘𝗧𝗔𝗕𝗢𝗟𝗜𝗖 𝗔𝗦𝗦𝗢𝗖𝗜𝗔𝗧𝗜𝗢𝗡𝗦

Type 2 diabetes mellitus
Cardiovascular risk factors
Dyslipidemia
Hypertension
Metabolic syndrome
Obstructive sleep apnea

𝗪𝗛𝗬 𝗧𝗛𝗘 𝗡𝗔𝗠𝗘 𝗖𝗛𝗔𝗡𝗚𝗘?

The term “PCOS” was considered misleading because:

Not all patients have ovarian cysts
The disorder involves much more than ovaries alone
Metabolic and endocrine abnormalities are central to disease pathology

The term “PMOS” better reflects the multisystem nature of the condition.

𝗨𝗣𝗗𝗔𝗧𝗘𝗗 𝗡𝗢𝗠𝗘𝗡𝗖𝗟𝗔𝗧𝗨𝗥𝗘: Published in 𝗧𝗵𝗲 𝗟𝗮𝗻𝗰𝗲𝘁 — May 12, 2026

Obg marathon